JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Enochs, W. S.
Right arrow Articles by Swartz, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Enochs, W. S.
Right arrow Articles by Swartz, H. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*MINOCYCLINE

The minocycline-induced thyroid pigment and several synthetic models: identification and characterization by electron paramagnetic resonance spectroscopy

WS Enochs, MJ Nilges and HM Swartz

University of Illinois College of Medicine, Urbana.

A distinctive side-effect of exposure to minocycline is black pigmentation of the thyroid gland. Previous studies have identified an association between this side-effect and the ability of minocycline to competitively inhibit thyroid peroxidase, but extensive histochemical analyses have resulted in ambiguous definitions of the pigment. Electron paramagnetic resonance spectroscopy, an especially effective technique for investigating melanins, is used in the present study to show that the thyroid pigment is well-modeled by synthetic pigments generated by oxidation of minocycline in vitro, thus indicating that it is a polymeric product due to oxidation of minocycline in vivo by thyroid peroxidase. The results demonstrate that pigments derived from minocycline comprise a novel class of pigments with redox and paramagnetic characteristics which are melanin-like in most respects yet are fundamentally unique. They also indicate that the thyroid pigment contains a large quantity of Fe bound tightly in situ, a finding with important pathophysiological implications in view of the redox properties of the pigment. The binding of Fe , however, also may provide a basis for noninvasively detecting the presence of pigmentation by magnetic resonance imaging of the thyroid. Other results of this study show that homogenizing tissues during the purification of any natural pigment can cause contamination of the pigment by extraneous metal ions and that subsequent incubation in hot acid, although most effective in removing metal ions and hydrolyzing tissue proteins, leads to degradation of melanin. By comparison, a purification procedure utilizing incubation in acid at room temperature generally is well-suited for identifying and characterizing natural melanins by electron paramagnetic resonance spectroscopy, but is inadequate for the thyroid pigment.

Volume 266, Issue 3, pp. 1164-1176, 09/01/1993
Copyright © 1993 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Arch DermatolHome page
D. M. Ozog, D. S. Gogstetter, G. Scott, and A. A. Gaspari
Minocycline-Induced Hyperpigmentation in Patients With Pemphigus and Pemphigoid
Arch Dermatol, September 1, 2000; 136(9): 1133 - 1138.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J.-i. Abe, J.-o Deguchi, T. Matsumoto, N. Takuwa, M. Noda, M. Ohno, M. Makuuchi, K. Kurokawa, and Y. Takuwa
Stimulated Activation of Platelet-Derived Growth Factor Receptor In Vivo in Balloon-Injured Arteries : A Link Between Angiotensin II and Intimal Thickening
Circulation, September 16, 1997; 96(6): 1906 - 1913.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1993 by the American Society for Pharmacology and Experimental Therapeutics.